Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1330591
European Journal of Endocrinology, Vol 133, Issue 5, 591-597
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clifton, V. L
Right arrow Articles by Smith, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Clifton, V. L
Right arrow Articles by Smith, R.

Identification and characterization of a corticotrophin-releasing hormone receptor in human placenta

Vicki L Clifton, Phillip C Owens, Phillip J Robinson and Roger Smith

Clifton VL, Owens PC, Robinson PJ, Smith R. Identification and characterization of a corticotrophinreleasing hormone receptor in human placenta. Eur J Endocrinol 1995;133:591–7. ISSN 0804–4643

Corticotrophin-releasing hormone (CRH) causes vasodilatation in the human fetal–placental circulation and has paracrine actions in placental tissue, suggesting that CRH receptors may be present in the human placenta. We have now identified and characterized placental CRH binding sites and compared them to those described previously in human myometrium and rat pituitary. Radiolabelled ovine CRH binding to placental membranes was pH-, time-, temperature- and divalent cation-dependent and was reversible in the presence of 1 µmol/l unlabelled ovine CRH. Scatchard analysis of placentae delivered vaginally or by elective caesarean section revealed dissociation constants (Kd) of 214.5 ± 84 pmol/l (N = 8) and 45.4 ± 23.9 pmol/l (N = 9), respectively. The Kd for caesarean placental binding sites was similar to that of human myometrium (59.6 pmol/l, N = 3) and rat pituitary (82.5 pmol/l, N = 3) receptors. However, in vaginally delivered placentae the CRH binding sites had a much lower affinity (p < 0.05). The receptor densities (Bmax) of vaginally delivered and caesarean-delivered placentae were 28.6 ± 9.6 and 6.1 ± 2.8 fmol/mg, respectively (p < 0.05). Chemical cross-linking studies using disuccinimidyl suberate indicated that the molecular weight of the CRH receptor in the placenta and rat pituitary is 75 kD. We conclude that there is a high-affinity population of CRH binding sites in the human placenta that are physicochemically similar to pituitary and myometrial CRH receptors. The CRH receptor properties in the placenta change in response to labour, when CRH levels in maternal blood are highest, suggesting that placental CRH may regulate its receptor.

R Smith, Endocrinology Unit, John Hunter Hospital, Locked Bag 1, Hunter Regional Mail Centre, Newcastle, NSW 2310, Australia




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Cao, N. Papadopoulou, D. Kempuraj, W. S. Boucher, K. Sugimoto, C. L. Cetrulo, and T. C. Theoharides
Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor
J. Immunol., June 15, 2005; 174(12): 7665 - 7675.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Karteris, A. Goumenou, E. Koumantakis, E. W. Hillhouse, and D. K. Grammatopoulos
Reduced Expression of Corticotropin-Releasing Hormone Receptor Type-1{alpha} in Human Preeclamptic and Growth-Restricted Placentas
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Karteris, D. Grammatopoulos, H. Randeva, and E. W. Hillhouse
Signal Transduction Characteristics of the Corticotropin-Releasing Hormone Receptors in the Feto-Placental Unit
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1989 - 1996.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Petraglia, P. Florio, C. Benedetto, L. Marozio, A. M. Di Blasio, C. Ticconi, E. Piccione, S. Luisi, A. R. Genazzani, and W. Vale
Urocortin Stimulates Placental Adrenocorticotropin and Prostaglandin Release and Myometrial Contractility in Vitro
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1420 - 1423.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Korebrits, M. M. Ramirez, L. Watson, E. Brinkman, A. D. Bocking, and J. R. G. Challis
Maternal Corticotropin-Releasing Hormone Is Increased with Impending Preterm Birth
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1585 - 1591.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. Heinrich, M. R. Meyer, J. Furkert, A. Sasse, M. Beyermann, W. Bonigk, and H. Berger
Corticotropin-Releasing Factor (CRF) Agonists Stimulate Testosterone Production in Mouse Leydig Cells through CRF Receptor-1
Endocrinology, February 1, 1998; 139(2): 651 - 658.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.